Down-regulation of habenular calcium-dependent secretion activator 2 induces despair-like behavior.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 02 2021
12 02 2021
Historique:
received:
14
08
2020
accepted:
29
01
2021
entrez:
13
2
2021
pubmed:
14
2
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Calcium-dependent secretion activator 2 (CAPS2) regulates the trafficking and exocytosis of neuropeptide-containing dense-core vesicles (DCVs). CAPS2 is prominently expressed in the medial habenula (MHb), which is related to depressive behavior; however, how MHb neurons cause depressive symptoms and the role of CAPS2 remains unclear. We hypothesized that dysfunction of MHb CAPS neurons might cause defects in neuropeptide secretion and the activity of monoaminergic centers, resulting in depressive-like behaviors. In this study, we examined (1) CAPS2 expression in the habenula of depression animal models and major depressive disorder patients and (2) the effects of down-regulation of MHb CAPS2 on the animal behaviors, synaptic transmission in the interpeduncular nucleus (IPN), and neuronal activity of monoamine centers. Habenular CAPS2 expression was decreased in the rat chronic restraint stress model, mouse learned helplessness model, and showed tendency to decrease in depression patients who died by suicide. Knockdown of CAPS2 in the mouse habenula evoked despair-like behavior and a reduction of the release of DCVs in the IPN. Neuronal activity of IPN and monoaminergic centers was also reduced. These results implicate MHb CAPS2 as playing a pivotal role in depressive behavior through the regulation of neuropeptide secretion of the MHb-IPN pathway and the activity of monoaminergic centers.
Identifiants
pubmed: 33580180
doi: 10.1038/s41598-021-83310-0
pii: 10.1038/s41598-021-83310-0
pmc: PMC7881199
doi:
Substances chimiques
CAPS2 protein, mouse
0
CAPS2 protein, rat
0
Calcium-Binding Proteins
0
Nerve Tissue Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3700Références
J Comp Neurol. 2006 Apr 20;495(6):735-53
pubmed: 16506193
Science. 2009 May 22;324(5930):1080-4
pubmed: 19389999
Cell Rep. 2019 Jan 29;26(5):1128-1142.e7
pubmed: 30699344
PLoS One. 2014 Apr 14;9(4):e94771
pubmed: 24733061
Trends Pharmacol Sci. 2017 Feb;38(2):169-180
pubmed: 27890353
J Biol Chem. 2003 Dec 26;278(52):52802-9
pubmed: 14530279
J Neurosci. 2007 Mar 7;27(10):2472-82
pubmed: 17344385
Neurobiol Dis. 2011 Apr;42(1):116-24
pubmed: 21232602
Eur J Neurosci. 2004 May;19(9):2551-60
pubmed: 15128408
Psychoneuroendocrinology. 1993;18(7):509-19
pubmed: 7903467
Rev Neurosci. 2019 Apr 24;30(3):289-303
pubmed: 30173207
Mol Psychiatry. 2017 Jun;22(6):920-930
pubmed: 27821870
Psychopharmacology (Berl). 2005 Apr;178(4):381-8
pubmed: 15551069
Genomics. 2003 Mar;81(3):279-91
pubmed: 12659812
Neurosci Lett. 2017 Nov 20;661:121-125
pubmed: 28963059
J Neurosci. 2013 Nov 13;33(46):18022-35
pubmed: 24227714
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):373-8
pubmed: 21173225
Psychoneuroendocrinology. 1984;9(3):233-48
pubmed: 6149588
Neuroscience. 2001;106(4):783-92
pubmed: 11682163
Neurosci Lett. 2018 Jun 11;677:65-71
pubmed: 29689341
Nat Rev Neurosci. 2010 Jul;11(7):503-13
pubmed: 20559337
FEBS Lett. 2013 Jan 4;587(1):54-9
pubmed: 23159942
Neuropsychopharmacology. 2002 May;26(5):615-24
pubmed: 11927186
Behav Brain Res. 2017 Mar 30;322(Pt A):138-144
pubmed: 28062258
Sci Rep. 2017 Apr 18;7(1):900
pubmed: 28420875
Nature. 2013 Jan 24;493(7433):537-541
pubmed: 23235822
Front Behav Neurosci. 2018 Oct 09;12:238
pubmed: 30356828
Psychopharmacology (Berl). 1993;113(1):31-6
pubmed: 7862825
Neuron. 2011 Feb 10;69(3):445-52
pubmed: 21315256
Neuropsychopharmacology. 2019 Mar;44(4):793-804
pubmed: 30420603
J Neurosci. 2014 Aug 20;34(34):11366-84
pubmed: 25143617
J Comp Neurol. 2012 Dec 15;520(18):4051-66
pubmed: 22700183
J Clin Invest. 2007 Apr;117(4):931-43
pubmed: 17380209
Neuron. 2012 Oct 4;76(1):98-115
pubmed: 23040809
J Comp Neurol. 2017 Jul 1;525(10):2411-2442
pubmed: 28340505
Mol Neurobiol. 2009 Feb;39(1):62-72
pubmed: 19160073
Curr Neuropharmacol. 2007 Dec;5(4):244-52
pubmed: 19305741
J Comp Neurol. 1981 Feb 20;196(2):253-70
pubmed: 7217357
Front Behav Neurosci. 2013 Mar 12;7:17
pubmed: 23487260
Front Psychiatry. 2019 Feb 28;10:100
pubmed: 30873055
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5429-34
pubmed: 27114535
Front Endocrinol (Lausanne). 2013 Dec 04;4:187
pubmed: 24363652
J Neurosci. 2013 Aug 28;33(35):13978-88, 13988a
pubmed: 23986235
Eur J Pharmacol. 2000 Jan 10;387(2):R9-10
pubmed: 10650166
J Proteome Res. 2018 Apr 6;17(4):1463-1473
pubmed: 29518334
J Comp Neurol. 1979 Sep 1;187(1):19-47
pubmed: 226566
Exp Neurobiol. 2019 Dec 31;28(6):709-719
pubmed: 31902158
eNeuro. 2016 Jul 18;3(3):
pubmed: 27482535
J Neurosci. 2004 Jan 7;24(1):43-52
pubmed: 14715936
Physiol Rev. 2014 Jan;94(1):265-301
pubmed: 24382888
Nat Commun. 2014 Nov 12;5:5390
pubmed: 25388237
Cell Rep. 2014 Sep 25;8(6):1857-1869
pubmed: 25242321
Neuron. 2004 Aug 19;43(4):551-62
pubmed: 15312653